Contact
s.boddu@ajman.ac.ae
06 705 null
Ajman Campus
Sai Hanuman Sagar Boddu

Dr. Sai H.S. Boddu is a Professor of Pharmaceutics in the College of Pharmacy and Health Sciences at Ajman University (AU). He earned his Ph.D. in Pharmaceutical Sciences from the University of Missouri-Kansas City. Before joining AU, Dr. Boddu spent 7.5 years at the University of Toledo. He holds two patents and has published over 120 research and review articles in various peer-reviewed journals. Dr. Boddu is also a co-editor of the book Excipient Applications in Formulation Design and Drug Delivery. Additionally, he serves as Associate Editor for Cancer Reports and Scientific Advisor for the Journal of Pharmaceutical Sciences. An active member of the American Association of Pharmaceutical Scientists (AAPS), Dr. Boddu's current research focuses on developing novel drug delivery systems for treating a range of diseases, particularly retinal diseases.

Education
  • Ph.D. in Pharmaceutical Sciences, University of Missouri-Kansas City, USA, 2010.
  • Master's in Pharmaceutics, NDMVP Samaj's College of Pharmacy, Nashik, Maharashtra, India.
  • Bachelor's in Pharmaceutics, Bapatla College of Pharmacy, Bapatla, Andhra Pradesh, India.
Experience
  • Associate Professor, Department of Pharmaceutical Sciences, Ajman University, Ajman, UAE, August 2018 – 2022.
  • Associate Professor, Department of Pharmacy Practice, University of Toledo, USA, August 2016 – August 2018.
  • Assistant Professor, Department of Pharmacy Practice, University of Toledo, USA, February 2011 – August 2016.
  • Research Associate, Wockhardt Research Center, Chikalthana, Aurangabad, Maharashtra, India, August 2005 – August 2006.
  • Professor, Department of Pharmaceutical Sciences, Ajman University, Ajman, UAE, August 2022 – present.
Teaching Area
  • Pharmaceutics, Dosage forms, Pharmacokinetics
  • Biopharmaceutics
  • Clinical Pharmacokinetics
  • Pharmaceutical Technology
  • Pharmaceutical Biotechnology
Research
  • Drug Delivery, Novel Drug Delivery Systems, Bioanalysis, Pharmacokinetics, Nanotechnology.
Publications
Conference Presentation
  • Peeters MJ, Cor MK, Boddu SHS, Nesamony J, Applying Generalizability Theory to Provide Validity Evidence for a Pharmaceutics Course Grade: Combining Exam Reliability Coefficients. 119th Annual Meeting of the American Association of Colleges of Pharmacy, Boston, Massachusetts, July 21-25, 2018
  • Sai HS. Boddu, ​Ultrasound-mediated Transdermal Delivery of Econazole Nitrate For Treating Raynaud's Phenomenon​ at the 2019 Controlled Release Society Annual Meeting & Exposition in Valencia, Spain, July 21-24, 2019
  • Boddu SHS et al., “Ultrasound-mediated Transdermal Delivery of Econazole Nitrate For Treating Raynaud's Phenomenon” at the 2019 Controlled Release Society Annual Meeting & Exposition in Valencia, Spain, July 21-24, 2019
  • Bolla PK, Boddu SHS et al., Development and In Vitro Characterization of Folate Conjugated PLGA Nanoparticles of Lutein, AAPS 2020 New Orleans in USA, Oct 26- 28, 2020
Memberships, Awards and Honors
  • University of Missouri-Kansas City, Vice Chancellor for Student Affairs and Enrollment Management Honor Recipient, Fall 2010.
  • University of Missouri-Kansas City – Chancellor's Doctoral Fellowship, Fall 2008 – Fall 2010.
  • University of Missouri-Kansas City – Chancellor Non-Resident Award, Fall 2006 – Fall 2010.
  • University of Missouri-Kansas City, Best Poster Award for Research Day, 2010.
  • AAPS-UMKC Best Seminar Speaker Award, 2008.
  • University of Missouri-Kansas City, 24th Annual Achievers of Excellence Award, 2006.
  • Principal Investigator, "Design and Characterization of an Improved Lidocaine HCl Formulation for Dental Procedures" Research Contract Grant, Funded by: Neocaine, LLC, USA, AED 440,760.00 (Funded), 06/2020 – 06/2022.
  • Principal Investigator, "Taste Masking of Injectable Lidocaine HCl Formulation for Dental Procedures," Interdisciplinary Research Grant, Funded by: Ajman University, Date: October 1st, 2019 (Funded), 10/2019 – 09/2020, Amount: AED 49,760.
  • Principal Investigator, "Development and Characterization of Nicotine-Loaded Solid Lipid Nanoparticle Hydrogels," Sponsor: Paso del Norte Health Foundation, Prime Grantee: The University of Texas at El Paso, 1/1/2018 to 2/28/2019, Amount: $11,000.
  • Principal Investigator, "Development and Validation of an SPME-GC-MS Method for Determination of Fluasterone in Rabbit Plasma," University of Texas at El Paso, Date: 7/1/2018 – 8/31/2018, Amount: $8,000.
  • Principal Investigator, "Development and Characterization of Tanshinone IIA Microparticles for Sustained Therapy in Age-Related Macular Degeneration," University of Toledo, Date: 06/12/2017, Amount: $5,000.
  • Principal Investigator, "In Vitro Release of Model Drugs from Silicone-Based Elastomers and Elastomer Gels," Wacker Chemical Corporation, Date: 12/12/2016, Amount: $30,500.
  • Principal Investigator, "Solubility and Stability of Diazepam in Selected Solvents," Total Care Pharmacy, Date: 12/12/2016, Amount: $6,500.
  • Principal Investigator, "Electrospun Ophthalmic Inserts for Extended Delivery of Bimatoprost in Glaucoma Therapy," deArce-Koch Memorial Endowment Fund in Support of Medical Research and Development, Date: 05/01/2015 – 05/01/2016, Amount: $10,000.
  • Principal Investigator, "To Study the Dermal Absorption of Cosmetic Products Across Fresh Human Tissue Samples," L’Oréal Collaborative Project, Date of Submission: 06/27/2014, Amount: $12,483.
  • Principal Investigator, “Preparation and Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic acid for the Transdermal Delivery of Ketoprofen”, International Academy of Compounding Pharmacists”, Date: 02/01/2013 - 02/01/2014, Amount: $ 9,980.
  • Co-Investigator, “Waters Academic Grant Program”, Duration: 10/30/2012 - 10/29/2014.
  • Co-Investigator, "Preclinical Evaluation of Photodynamic Therapy for the Treatment of Chronic Sinusitis," The Translational Research Stimulation Award Program, Principal Investigator: Reginald Baugh, MD, Professor of Surgery, Date: 05/01/2012 – 05/01/2013, Amount: $25,000.00.
  • Collaborating Investigator, "Novel Trans-Scleral Delivery Strategy Using Bimatoprost Nanoparticles Given Subconjunctivally for the Treatment of Glaucoma," St. Luke’s Hospital Foundation, Amount: $24,600.00, Date: 11/01/2009 – 10/31/2010.
  • Principal Investigator, "Preliminary Evaluation of Thermoresponsive Gels Containing Nanoparticles Loaded with Nicotine-Stearic Acid Conjugate for Intranasal Use in Smoking Cessation," Interdisciplinary Research Grant, Funded by: Ajman University, Date: October 1st, 2021, Amount: AED 32,500, Status: Ongoing.
  • Co-Investigator, "Evaluation of Whole Grape-Drug Pharmacokinetic Interactions and Toxicity," Interdisciplinary Research Grant, Funded by: Ajman University, Date: October 1st, 2021, Amount: AED 50,000, Status: Ongoing.
  • Principal Investigator, "Nanoparticle-Laden Contact Lens for Controlled Delivery of Acetazolamide in the Treatment of Glaucoma," Interdisciplinary Research Grant, Funded by: Ajman University, Date: October 1st, 2022, Amount: AED 20,000, Status: Ongoing.
  • Principal Investigator, "Development and Characterization of Novel Multilayer Nanofiber Insert Loaded with Dexamethasone for Treating Dry Eye Disease," Interdisciplinary Research Grant, Funded by: Ajman University, Date: October 1st, 2022, Amount: AED 45,700, Status: Ongoing.
  • Reviewer for National Research, Development and Innovation Office, Hungary, 2023.
  • Excellence Award, BioMe’23, Hyderabad, India, 2023.
  • AU Honors Best Researcher Award (2022-2023)
  • Top 2% of Global Scientists in Stanford University's 2024 List.